SCHEMBL24435294

SCHEMBL24435294

CC(C)OC(C)(C)c1csc(NC(=O)c2cccn2Cc2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN3A Q9NY46 4/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KCNH2 Q12809 1/20 0.47
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
CNR2 P34972 5/20 0.41
CNR1 P21554 2/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
POLB P06746 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 2/20 0.41
PKM P14618 1/20 0.41
SCN5A Q14524 1/20 0.40
SCN9A Q15858 1/20 0.40
TP53 P04637 4/20 0.40
MAPK1 P28482 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24434845 0.93 SMN1; SMN2 (0.45) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24434540 0.90 SCN3A (0.41) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24434687 0.90 SCN3A (0.45) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24434576 0.90 SCN3A (0.48) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24434967 0.90 NPC1 (0.44) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24434808 0.89 KDM4E (0.40) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24435339 0.89 LMNA (0.44) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24434549 0.89 MEN1 (0.46) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL24434544 0.89 CNR2 (0.41) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL31466331 0.89 SCN3A (0.40) SCN3ACYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3930849-B1 THIAZOLE DERIVATIVES AS PROTEIN SECRETION INHIBITORS KEZAR LIFE SCIENCES (US) 2025-02-19 EP disclosed
WO-2023010051-A1 PROTEIN SECRETION INHIBITORS GATE BIOSCIENCE, INC. (US) 2023-02-02 WO disclosed
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G SCN3A 1699/4885CYP1A2 3277/4885CYP2D6 3197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.